ArticleCureus2025
Retrospective Evaluation of the Efficacy of Prophylactic Antibiotics in Preventing Surgical Site Infections in Elliptical Skin Biopsy.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incidence of post-operative infections and antibiotic resistance trends: A clinical study.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionElliptical skin biopsy is a commonly performed dermatologic procedure that provides sufficient tissue for histopathologic diagnosis and additional testing. However, concerns remain regarding the risk of surgical site infection (SSI), leading to the widespread use of prophylactic antibiotics despite the lack of clear supporting evidence. This study aimed to evaluate whether prophylactic antibiotic administration reduces SSI risk following elliptical biopsy. METHODOLOGY: A retrospective observational study was conducted at the University of Toyama, including 202 patients who underwent elliptical biopsy between October 2022 and July 2024. Among them, 146 (72.3%) received prophylactic antibiotics, while 56 (27.7%) did not. The primary outcome was the incidence of SSI within 30 days post procedure. Multivariable logistic regression and inverse probability of treatment weighting (IPTW) were applied to adjust for potential confounders.
resultsSSI occurred at similar rates in both groups (prophylactic vs. non-prophylactic: 11.0% vs. 10.7%, p = 1.0), suggesting that antibiotic prophylaxis may not be effective in reducing infection risk. Neither multivariable logistic regression nor IPTW analysis demonstrated a significant association between prophylactic antibiotic use and SSI prevention. Additionally, clinicians with more years of experience were less likely to prescribe prophylactic antibiotics, indicating greater confidence in withholding antibiotics when not clinically necessary. In contrast, higher serum albumin levels were associated with greater antibiotic use. Although this association reached statistical significance, the actual difference in albumin levels (4.1 vs. 3.8 g/dL) is modest and likely lacks clinical relevance. These findings suggest that antibiotic prescribing may have been influenced more by physician discretion, particularly among less experienced clinicians, as well as by institutional practices, routine habits, or excessive concern about SSI risk, rather than by objective indicators of clinical need.
conclusionThese findings suggest that routine prophylactic antibiotic use after elliptical biopsy may not be necessary in dermatologic practice. Given increasing concerns about antimicrobial resistance and antibiotic shortages, optimizing antibiotic use is a critical consideration. Emphasizing alternative strategies, such as meticulous wound irrigation, postoperative care, and patient education, may help minimize SSI risk while ensuring safe wound healing. Further prospective studies with larger cohorts and standardized treatment protocols are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.